In the pithed rat we investigated the cardiovascular properties of d,l-nebivolol and its enantiomers. We used the increase in heart rate elicited by (–)-adrenaline and (–)-noradrenaline as a model for studying β1-adrenoceptors. A leftward shift of the logarithmic dose-pressor response curve of (–)-adrenaline reflects β2-adrenoceptor-blocking properties. The blood pressure responses of methoxamine, B-HT 920 and serotonin (5-HT) were studied in order to test whether d,l-nebivolol has α1-, α2- and 5-HT2-receptor-blocking properties. Furthermore, the interaction of d,l-nebivolol with the peripheral sympathetic neurotransmission was investigated in pithed rats by electrical stimulation of the spinal cord. d,l-Nebivolol and d-nebivolol (threshold concentration 10–8 mol/kg) were demonstrated to be selective β1-adrenoceptor antagonists. l-Nebivolol was a factor of 1,000 less potent as β1-adrenoceptor blocker. Up to a dose of 10-5 mol/kg, d,l-nebivolol appeared to have neither α1-, α2 β2-, 5-HT2-, angiotensin II-receptor antagonistic, calcium entry blocking, converting enzyme inhibiting nor direct vasodilating properties and did not interact with the sympathetic neurotransmission in the vascular wall. An explanation for an antihypertensive effect independent of β-adrenoceptor blockade as found in spontaneously hypertensive rats and man could not be found in this model, therefore we suggest that this blood-pressure-lowering effect does not originate from conventional peri